CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling

Published:2006-05 Issue:5 Volume:8 Page:394-401
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Wan Xiaolin,Shen Na,Mendoza Arnulfo,Khanna Chand,Helman Lee J.

Publisher

Elsevier BV

Subject

Cancer Research

Reference48 articles.

1. Rhabdomyosarcoma: an overview;Dagher;Oncologist,1999

2. Head and neck rhabdomyosarcoma;Wiener;Semin Pediatr Surg,1994

3. Pediatric genitourinary tumors;Merguerian;Curr Opin Oncol,2002

4. Rhabdomyosarcoma and other soft tissue sarcoma in children;Pappo;Curr Opin Oncol,1996

5. Rhabdomyosarcoma and soft tissue sarcoma in childhood;Womer;Curr Opin Oncol,2000

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fusion-negative rhabdomyosarcoma orthotopic tongue xenografts for study of invasion, intravasation and metastasis in live animals;2023-09-23

2. Vincristine/irinotecan/temsirolimus upfront window treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee;Pediatric Blood & Cancer;2023-04-19

3. Machine Learning Screening for Disulfidptosis Genes-Associated Immunosuppression Status in Osteosarcoma and Rhabdomyosarcoma;2023

4. GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion–positive rhabdomyosarcoma;JCI Insight;2022-12-08

5. Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1α Signaling Pathway and Suppressing Oxidative Stress;Oxidative Medicine and Cellular Longevity;2022-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3